Literature DB >> 10753713

The vaccinia virus bifunctional gene J3 (nucleoside-2'-O-)-methyltransferase and poly(A) polymerase stimulatory factor is implicated as a positive transcription elongation factor by two genetic approaches.

D R Latner1, Y Xiang, J I Lewis, J Condit, R C Condit.   

Abstract

Vaccinia virus genes A18 and G2 affect the elongation and termination of postreplicative viral gene transcription in opposite ways. Viruses with mutations in gene A18 produce abnormally long transcripts, indicating that A18 is a negative transcription elongation factor. Viruses containing mutations in gene G2 produce transcripts that are abnormally short, truncated specifically from their 3' ends, indicating that G2 is a positive transcription elongation factor. Despite the fact that both A18 and G2 are essential genes, A18-G2 double-mutant viruses are viable, presumably because the effects of the mutations are mutually compensatory. In addition, the anti-poxviral drug isatin-beta-thiosemicarbazone (IBT) seems to enhance elongation during a vaccinia infection: IBT treatment of a wildtype vaccinia infection induces a phenotype identical to an A18 mutant infection, and G2 mutant viruses are dependent on IBT for growth, presumably because IBT restores the G2 mutant truncated transcripts to a normal length. These observations inspire two independent genetic selections that have now been used to identify an additional vaccinia gene, J3, that regulates postreplicative transcription elongation. In the first selection, a single virus that contains an extragenic suppressor of the A18 temperature-sensitive mutant, Cts23, was isolated. In the second selection, several spontaneous IBT-dependent (IBT(d)) mutant viruses were isolated and characterized genetically. Marker rescue mapping and DNA sequence analysis show that the extragenic suppressor of Cts23 contains a point mutation in the J3 gene, while each of seven new IBT(d) mutants contains null mutations in the J3 gene. The J3 protein has previously been identified as a (nucleoside-2'-O-)-methyltransferase and as a processivity subunit for the heterodimeric viral poly(A) polymerase. The nature of the two independent selections used to isolate the J3 mutants strongly suggests that the J3 protein serves as a positive postreplicative transcription elongation factor during a normal virus infection. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753713     DOI: 10.1006/viro.2000.0243

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Marker rescue mapping of the combined Condit/Dales collection of temperature-sensitive vaccinia virus mutants.

Authors:  Sayuri E M Kato; Nissin Moussatche; Susan M D'Costa; Travis W Bainbridge; Cindy Prins; Audra L Strahl; Amber N Shatzer; Alyson J Brinker; Nicole E Kay; Richard C Condit
Journal:  Virology       Date:  2008-03-07       Impact factor: 3.616

2.  Vaccinia H5 is a multifunctional protein involved in viral DNA replication, postreplicative gene transcription, and virion morphogenesis.

Authors:  Susan M D'Costa; Travis W Bainbridge; Sayuri E Kato; Cindy Prins; Karen Kelley; Richard C Condit
Journal:  Virology       Date:  2010-03-05       Impact factor: 3.616

3.  Genetic Confirmation that the H5 Protein Is Required for Vaccinia Virus DNA Replication.

Authors:  Kathleen A Boyle; Matthew D Greseth; Paula Traktman
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

4.  A targeted approach to identification of vaccinia virus postreplicative transcription elongation factors: genetic evidence for a role of the H5R gene in vaccinia transcription.

Authors:  Steven G Cresawn; Richard C Condit
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

Review 5.  Orthopoxvirus targets for the development of antiviral therapies.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Curr Drug Targets Infect Disord       Date:  2005-03

6.  Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus.

Authors:  William D Arndt; Stacy D White; Brian P Johnson; Trung Huynh; Jeffrey Liao; Heather Harrington; Samantha Cotsmire; Karen V Kibler; Jeffrey Langland; Bertram L Jacobs
Journal:  Virology       Date:  2016-07-26       Impact factor: 3.616

7.  Vaccinia virus temperature-sensitive mutants in the A28 gene produce non-infectious virions that bind to cells but are defective in entry.

Authors:  Peter C Turner; Bradley P Dilling; Cindy Prins; Steven G Cresawn; Richard W Moyer; Richard C Condit
Journal:  Virology       Date:  2007-05-17       Impact factor: 3.616

8.  Biochemical and biophysical properties of a putative hub protein expressed by vaccinia virus.

Authors:  Nicole E Kay; Travis W Bainbridge; Richard C Condit; Michael R Bubb; Reuben E Judd; Balasubramanian Venkatakrishnan; Robert McKenna; Susan M D'Costa
Journal:  J Biol Chem       Date:  2013-03-08       Impact factor: 5.157

9.  An Amsacta moorei entomopoxvirus ortholog of the poly(A) polymerase small subunit exhibits methyltransferase activity and is non-essential for virus growth.

Authors:  Marie N Becker; Tracie M Todd; Richard W Moyer
Journal:  Virology       Date:  2008-03-26       Impact factor: 3.616

10.  Interaction of the vaccinia virus RNA polymerase-associated 94-kilodalton protein with the early transcription factor.

Authors:  Zhilong Yang; Bernard Moss
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.